DPYD and hyperinsulinemic hypoglycemia, familial, 4: Up front screening of DPD deficiency through genotyping for high-risk DPYD variants (DPYD *2A, *13 and *9B) only is suboptimal to predict fluoropyrimidine-related toxicity.